was founded by veteran scientists from world-renowned pharmaceutical companies and academic institute to develop innovative bispecific antibody therapeutics and biobetter medicines. The company is located in Shenzhen, China. The founders of the company come from several different yet complementary scientific disciplines in the drug development industry. They are inventors of numerous patents and possess rich experiences in leading a team to develop new biological drugs in the biopharmaceutical industry. Recently, SZEB scientists have developed patented technology DSP-BsAb, which could be used to create first-class bispecific antibody therapeutics for cancer immunotherapy as well as for combination therapy with synergistic effect.